Momenta Pharmaceuticals is Drug Discovery in United States that focus on Several innovative drugs business. Founded in 2001. They cover business area such as Momenta, development, innovative drug, autoimmune disease, its legacy business, complex generic version, MS drug Copaxone, Lovenox, royalty, these product, Novartis, Eylea, biosimilar, nipocalimab.
2001
( 23 years old in 2024 )
Several Innovative Drugs
-
301 Binney Street
Cambridge, MA 02142
United States
Private
Momentadevelopmentinnovative drugautoimmune diseaseits legacy businesscomplex generic versionMS drug CopaxoneLovenoxroyaltythese productNovartisEyleabiosimilarnipocalimab
* We use standard office opening hours in near Momenta Pharmaceuticals's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Momenta Pharmaceuticals is Drug Discovery business from United States that founded in 2001 (23 years old in 2024), Momenta Pharmaceuticals business is focusing on Several Innovative Drugs.
Momenta Pharmaceuticals headquarter office and corporate office address is located in 301 Binney Street Cambridge, MA 02142 United States.
Momenta Pharmaceuticals was founded in United States.
In 2024, Momenta Pharmaceuticals is currently focus on Several innovative drugs sector.
Above is snippet of Google Trends for "Several innovative drugs" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Momenta Pharmaceuticals, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
